NURS6630-Week 11 Final Exam-2020

Document Content and Description Below

NURS6630-Week 11 Final Exam-2020 Course NURS-6630N-,Approaches to Treatment.2020 Spring Qtr 02/24-05/17- Test Week 11 Final Exam Due Date 5/11/20 1:59 AM Status Completed Attempt Score 72 out... of 75 points Time Elapsed 1 hour, 40 minutes out of 2 hours Results Displayed Submitted Answers 1. When completing this exam, did you comply with Walden University’s Code of Conduct including the expectations for academic integrity? Selected Ye Answer: s 2. All drugs that lead to addiction increase in the ventral striatum, which is also called the . Selected Answer: a. Dopamine / nucleus accumbens 3. A patient with chronic back pain has been prescribed a serotonin-norepinephrine reuptake inhibitor (SNRI). How does the PMHNP describe the action of SNRIs on the inhibition of pain to the patient? Selected Answer: a. “The SNRI can increase noradrenergic neurotransmission in the descending spinal pathway to the dorsal horn.” 4. Karen completes the Epworth sleepiness scale and scores abnormally high. She is diagnosed with narcolepsy. The PMHNP prescribes a wake-promoting agent that is a weak dopamine transporter antagonist. Which medication did the PMHNP prescribe? Selected Answer: a. Modafanil (PROVIGIL) 5. Which of these characteristics does NOT meet the criteria for probably Alzheimer's dementia? Selected Answer: b. Sudden onset 6. Neal is complaining of restless leg syndrome and insomnia. Which first-line medication should the PMHNP prescribe to treat both? Selected Answer: a. Ripinirole (REQUIP) 7. A nursing student asks the PMHNP about the difference between the use of stimulants in the treatment of ADHD and the abuse of stimulants in substance-use disorders. Which is the correct response? CONTINUED.... [Show More]

Last updated: 2 years ago

Preview 1 out of 15 pages

Buy Now

Instant download

We Accept: